M
Manuel Wiesenfarth
Researcher at German Cancer Research Center
Publications - 47
Citations - 1620
Manuel Wiesenfarth is an academic researcher from German Cancer Research Center. The author has contributed to research in topics: Computer science & Prostate cancer. The author has an hindex of 16, co-authored 36 publications receiving 885 citations.
Papers
More filters
Journal ArticleDOI
Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment
Patrick Schelb,Simon A. A. Kohl,Jan Philipp Radtke,Jan Philipp Radtke,Manuel Wiesenfarth,Philipp Kickingereder,Philipp Kickingereder,Sebastian Bickelhaupt,Sebastian Bickelhaupt,Tristan Anselm Kuder,Albrecht Stenzinger,Markus Hohenfellner,Heinz Peter Schlemmer,Klaus H. Maier-Hein,David Bonekamp +14 more
TL;DR: U-Net trained with T2-weighted and diffusion MRI achieves similar performance to clinical Prostate Imaging Reporting and Data System assessment in the task of detection and segmentation of lesions suspicious for sPC.
Journal ArticleDOI
Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies.
Jan Philipp Radtke,Jan Philipp Radtke,Manuel Wiesenfarth,Claudia Kesch,Martin T. Freitag,Céline D. Alt,Kamil Celik,Florian Distler,Wilfried Roth,Kathrin Wieczorek,Christian Stock,Stefan Duensing,Matthias Roethke,Dogu Teber,Heinz Peter Schlemmer,Markus Hohenfellner,David Bonekamp,Boris Hadaschik +17 more
TL;DR: Both RM benefits exceeded those of ERSPC-RCs and PI-RADS in the decision regarding which patient to receive biopsy and enabled the highest reduction rate of unnecessary biopsies.
Journal ArticleDOI
Exploiting the potential of unlabeled endoscopic video data with self-supervised learning
Tobias Ross,David Zimmerer,Anant Vemuri,Fabian Isensee,Manuel Wiesenfarth,Sebastian Bodenstedt,Fabian Both,Philip Kessler,Martin Wagner,Beat Müller,Hannes Kenngott,Stefanie Speidel,Annette Kopp-Schneider,Klaus H. Maier-Hein,Lena Maier-Hein +14 more
TL;DR: In this article, the authors proposed a self-supervised learning approach for pre-training of CNNs for medical instrument segmentation using unlabeled video data from the target domain.
Journal ArticleDOI
Prediction of malignancy by a radiomic signature from contrast agent-free diffusion MRI in suspicious breast lesions found on screening mammography.
Sebastian Bickelhaupt,Daniel Paech,Philipp Kickingereder,Philipp Kickingereder,Franziska Steudle,Wolfgang Lederer,Heidi Daniel,Michael Götz,Nils Gählert,Diana Tichy,Manuel Wiesenfarth,Frederik Bernd Laun,Klaus H. Maier-Hein,Heinz Peter Schlemmer,David Bonekamp +14 more
TL;DR: To assess radiomics as a tool to determine how well lesions found suspicious on breast cancer screening X‐ray mammography can be categorized into malignant and benign with unenhanced magnetic resonance (MR) mammography with diffusion‐weighted imaging and T2‐weighting sequences is assessed.
Posted Content
The Medical Segmentation Decathlon
Michela Antonelli,Annika Reinke,Spyridon Bakas,Keyvan Farahani,AnnetteKopp-Schneider,Bennett A. Landman,Geert Litjens,Bjoern H. Menze,Olaf Ronneberger,Ronald M. Summers,Bram van Ginneken,Michel Bilello,Patrick Bilic,Patrick Ferdinand Christ,Richard K. G. Do,Marc J. Gollub,Stephan Heckers,Henkjan J. Huisman,William R. Jarnagin,Maureen McHugo,Sandy Napel,Jennifer S. Goli Pernicka,Kawal Rhode,Catalina Tobon-Gomez,Eugene Vorontsov,James A. Meakin,Sebastien Ourselin,Manuel Wiesenfarth,Pablo Arbeláez,Byeonguk Bae,Sihong Chen,Laura Alexandra Daza,Jianjiang Feng,Baochun He,Fabian Isensee,Yuanfeng Ji,Fucang Jia,Namkug Kim,Ildoo Kim,Dorit Merhof,Akshay Pai,Beomhee Park,Mathias Perslev,Ramin Rezaiifar,Oliver Rippel,Ignacio Sarasua,Wei Shen,Jaemin Son,Christian Wachinger,Liansheng Wang,Yan Wang,Yingda Xia,Daguang Xu,Zhanwei Xu,Yefeng Zheng,Amber L. Simpson,Lena Maier-Hein,M. Jorge Cardoso +57 more
TL;DR: The Medical Segmentation Decathlon (MSD) as mentioned in this paper was organized to evaluate the performance of image segmentation algorithms given a specific clinical problem and a set of unseen clinical problems, such as unbalanced labels, multi-site data and small objects.